Weight gain associated with use of psychotropic medications.
about
Clinically significant weight gain 1 year after occupational back injuryReview of the use of Topiramate for treatment of psychiatric disordersAdd-on topiramate reduces weight in overweight patients with affective disorders: a clinical case seriesMajor factors for facilitating change in behavioral strategies to reduce obesityChanges in body weight and psychotropic drugs: a systematic synthesis of the literatureQuantitative assessment of the bidirectional relationships between diabetes and depression.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.The relationship between obesity and psychiatric disorders across ethnic and racial minority groups in the United States.Weight gain and new onset diabetes associated with olanzapine and risperidone.The burden of obesity among adults with bipolar disorder in the United StatesTopiramate in Bipolar and Schizoaffective Disorders: Weight Loss and Efficacy.Retrospective Study of Olanzapine in Depressive and Anxious States in Primary Care.A behavioral weight-loss intervention for persons with serious mental illness in psychiatric rehabilitation centers.Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.Association between antipsychotics and weight gain among psychiatric outpatients in Pakistan: a retrospective cohort study.Examining a bidirectional association between depressive symptoms and diabetes.The neuropathology of obesity: insights from human disease.Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies
P2860
Q23910365-6BB6663E-90A4-4B7B-BEFF-BF03B775A3B7Q24523918-152B2E39-8E36-4317-BA5F-667D35A96BBBQ24793223-CA512455-4C68-4FAB-B0E6-ACF7CF6B026CQ27013049-2546E23C-2C4D-47B6-BC72-67CCDAEB6215Q28728401-ABE05F80-6DF3-4693-A97B-012F34627795Q33618693-C4CB3120-7B6A-46A1-93B9-3B5E74B47ABAQ34623350-22F20AF5-5164-4F42-B905-E466E787F609Q34644304-64BCE925-4A30-4606-885C-9AC5D111F5D3Q34733828-36EFEB41-BCD2-4167-AE86-85859650C256Q35167517-5BD4F621-109B-4C87-B56F-42EB9CB2144AQ35665140-5E839F32-BA57-4E67-91EA-6661550EBDAAQ35933068-0E75E6B4-2C73-4507-AF46-5B15FFED2527Q36130802-DB58AB99-5D5E-418B-BCEA-5904071123A0Q36774139-42AF881A-3AEA-4C33-9B52-E5F273EDD9DFQ36784587-9ACF4139-A8FC-4E46-8A39-EE1E0447E806Q36865463-4F413F31-5F9A-488B-987E-60339ECE5904Q37111643-686B8184-895E-4BB3-B025-DDBC7D3ACDC2Q37432600-DF0890AC-4945-4339-B6AF-1619096A96B3Q45065520-72ECFFCB-E57F-4110-82C1-D9C4C2A0BFC7Q58802216-BF45C725-E282-4C14-88FC-F525DBE8EB47
P2860
Weight gain associated with use of psychotropic medications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Weight gain associated with use of psychotropic medications.
@ast
Weight gain associated with use of psychotropic medications.
@en
type
label
Weight gain associated with use of psychotropic medications.
@ast
Weight gain associated with use of psychotropic medications.
@en
prefLabel
Weight gain associated with use of psychotropic medications.
@ast
Weight gain associated with use of psychotropic medications.
@en
P1476
Weight gain associated with use of psychotropic medications.
@en
P2093
P478
60 Suppl 21
P577
1999-01-01T00:00:00Z